We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Cigna to Support Cleerly's AI Cardiovascular Imaging Solutions
Read MoreHide Full Article
Key Takeaways
Cigna will cover Cleerly's AI cardiovascular imaging, joining UnitedHealthcare and EviCore.
The platform uses AI to detect arterial plaque with greater accuracy than traditional imaging.
Cigna posted 13% year-over-year revenue growth in the first half of 2025.
The Cigna Group (CI - Free Report) has made a significant move toward advancing digital healthcare by approving coverage for Cleerly’s AI-powered cardiovascular imaging technology. With this step, Cigna health plans now feature Cleerly LABS Advanced Plaque Analysis, joining UnitedHealthcare and EviCore. With Medicare's 2024 coverage decision and the new CPT I code for this technology set to launch in January 2026, major payors are now providing coverage for AI-QCT/AI-CPA to more than 61 million Americans, marking a significant milestone in industry adoption.
Cleerly’s platform harnesses the power of artificial intelligence to identify and measure plaque buildup in coronary arteries with a level of accuracy that surpasses traditional imaging methods. This innovative approach aims to help physicians identify high-risk patients earlier and tailor preventive measures, revolutionizing the management of heart disease, which continues to be the leading cause of death in the United States.
This development reflects the increasing role of AI in healthcare, especially in preventive care and population health management. As cardiovascular treatments are among the most expensive medical expenditures, earlier detection tools can help insurers manage risk by cutting down on hospitalization and emergency care costs.
This move highlights Cigna’s focus on integrating innovative technologies that improve patient outcomes while reducing long-term healthcare costs. This decision is part of a larger trend toward value-based care and digital advancements. By broadening access to AI-driven diagnostics, CI is solidifying its competitive edge in the industry.
For Cigna, this approach is expected to enhance customer loyalty and promote sustainable growth. In the first half of 2025, the company reported 13% year-over-year growth in total revenues.
How Are CI’s Competitors Faring?
Some of CI’s competitors in the value-based care space are UnitedHealth Group Incorporated (UNH - Free Report) , Elevance Health, Inc. (ELV - Free Report) and Humana Inc. (HUM - Free Report) .
With the help of its Optum division, UnitedHealth Group aims to reduce hospital admissions, enhance chronic condition management and improve patient satisfaction, which plays a crucial role in shaping outcomes and managing costs. In the first half of 2025, UnitedHealth Group reported 5.8% year-over-year growth in revenues in its Optum business.
Elevance Health is evolving beyond traditional insurance into a healthcare solutions provider. By expanding into primary care, digital health and pharmacy services, and partnering with value-based networks, Elevance Health aims to deliver integrated, patient-focused care that addresses preventive, behavioral and social health needs.
Humana also delivers services like pharmacy, primary care and home health solutions, which are designed to improve the overall healthcare experience. Humana’s total adjusted revenues rose 9.9% year over year in the first half of 2025.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Cigna to Support Cleerly's AI Cardiovascular Imaging Solutions
Key Takeaways
The Cigna Group (CI - Free Report) has made a significant move toward advancing digital healthcare by approving coverage for Cleerly’s AI-powered cardiovascular imaging technology. With this step, Cigna health plans now feature Cleerly LABS Advanced Plaque Analysis, joining UnitedHealthcare and EviCore. With Medicare's 2024 coverage decision and the new CPT I code for this technology set to launch in January 2026, major payors are now providing coverage for AI-QCT/AI-CPA to more than 61 million Americans, marking a significant milestone in industry adoption.
Cleerly’s platform harnesses the power of artificial intelligence to identify and measure plaque buildup in coronary arteries with a level of accuracy that surpasses traditional imaging methods. This innovative approach aims to help physicians identify high-risk patients earlier and tailor preventive measures, revolutionizing the management of heart disease, which continues to be the leading cause of death in the United States.
This development reflects the increasing role of AI in healthcare, especially in preventive care and population health management. As cardiovascular treatments are among the most expensive medical expenditures, earlier detection tools can help insurers manage risk by cutting down on hospitalization and emergency care costs.
This move highlights Cigna’s focus on integrating innovative technologies that improve patient outcomes while reducing long-term healthcare costs. This decision is part of a larger trend toward value-based care and digital advancements. By broadening access to AI-driven diagnostics, CI is solidifying its competitive edge in the industry.
For Cigna, this approach is expected to enhance customer loyalty and promote sustainable growth. In the first half of 2025, the company reported 13% year-over-year growth in total revenues.
How Are CI’s Competitors Faring?
Some of CI’s competitors in the value-based care space are UnitedHealth Group Incorporated (UNH - Free Report) , Elevance Health, Inc. (ELV - Free Report) and Humana Inc. (HUM - Free Report) .
With the help of its Optum division, UnitedHealth Group aims to reduce hospital admissions, enhance chronic condition management and improve patient satisfaction, which plays a crucial role in shaping outcomes and managing costs. In the first half of 2025, UnitedHealth Group reported 5.8% year-over-year growth in revenues in its Optum business.
Elevance Health is evolving beyond traditional insurance into a healthcare solutions provider. By expanding into primary care, digital health and pharmacy services, and partnering with value-based networks, Elevance Health aims to deliver integrated, patient-focused care that addresses preventive, behavioral and social health needs.
Humana also delivers services like pharmacy, primary care and home health solutions, which are designed to improve the overall healthcare experience. Humana’s total adjusted revenues rose 9.9% year over year in the first half of 2025.